Delivery Order SPE2DE24DA010-SPE2D626F66E1
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order on December 31, 2025, under contract number 4570556639 (GALLANT) with a fixed ceiling value of $25,875.85. This delivery order, issued by the Defense Logistics Agency's Medical Supply Chain, represents a continuation of Abbott's substantial federal contracting presence in cardiovascular medical technologies. The award carries no set-aside designation and was issued under a fixed-price structure with...
- Abbott Laboratories Inc.'s Abbott Vascular Inc. division received a $34,732.80 fixed-price delivery order (Contract No. 4570178737, "GALLANT") from the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with completion scheduled for December 4, 2025. The award, issued through full and open competition with no set-aside designation, supports the agency's medical supply procurement operations at Abbott's Santa Clara, California facility. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $25,875.85 on December 11, 2025, under a fixed-price contract with economic price adjustment terms. The award, designated as contract number 4570382323 (GALLANT), is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused procurement entity supporting the Department of Defense's medical device and equipment requirements. The place of performance is located...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $21,147 fixed-price delivery order (Contract 4570006266, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. The delivery order, issued without any small business set-aside, is for performance at Abbott's Santa Clara, California location. This award represents a task order under Abbott's established relationship with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $39,422.80 fixed-price delivery order (Contract 4570007649, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. This delivery order, which carries no set-aside designation, represents a task order issued against Abbott's broader $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a $34,732.80 fixed-price delivery order (Contract 4570380875, GALLANT) from the Defense Logistics Agency's Medical Supply Chain on December 11, 2025, with completion targeted for January 6, 2026. The delivery order, issued without set-aside designation, will be performed in Santa Clara, California, and represents a task order execution under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $60,563.90 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, with an ultimate completion date of September 19, 2025. The contract, designated as GALLANT (Contract Number 4569469210), was awarded without a set-aside designation, indicating full and open competition. The place of performance is located in Santa Clara, California. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order with economic price adjustment valued at $36,320.80 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025. This delivery order, designated as GALLANT (Contract Number 4569403310), was issued without set-aside provisions, indicating full and open competition. The contract will be performed in Santa Clara, California, with an ultimate completion date of September 15,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $24,350 from the Defense Logistics Agency Medical Supply Chain on December 18, 2025, with an ultimate completion date of December 23, 2025. The contract employs a fixed-price structure with economic price adjustment terms and carries no set-aside designation, reflecting full and open competition. Performance will occur at Abbott Vascular's Santa Clara, California location. This delivery...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F66E1Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award (Contract No. 4570376636, designated "GALLANT") from the Defense Logistics Agency Medical Supply Chain on December 30, 2025, with a ceiling value of $37,127.95 and an ultimate completion date of January 5, 2026. The contract utilizes a fixed-price structure with economic price adjustment pricing and will be performed in Santa Clara, California. No set-aside designation was used in this award, reflecting Abbott's competitive positioning in full and open competition for federal medical device procurement. This delivery order represents a discrete task order issued under Abbott Vascular's established relationship with the Defense Logistics Agency, which maintains a substantial $117.1 million Indefinite Delivery Contract with the company for comprehensive cardiovascular procedural packages encompassing devices, instrumentation, and accessories. Abbott Vascular has demonstrated consistent success in federal healthcare procurement, particularly through its cardiovascular medical technology portfolio including stents, pacemakers, heart valves, and specialized surgical implants, serving as a critical supplier to the Department of Veterans Affairs and Department of Defense across multiple Veterans Integrated Service Networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.1k | 12/29/25 |